Extendicare Announces June 2026 Dividend of C$0.0441 per Share
Markham, Ontario--(Newsfile Corp. - June 15, 2026) - Extendicare Inc. (TSX: EXE) ("Extendicare" or the "Company") announced that it has declared a cash dividend of C$0.0441 per common share of the Company for the month of June 2026, which is payable on July 15, 2026 to shareholders of record at the close of business on June 30, 2026. This dividend is designated as an "eligible dividend" within the meaning of the Income Tax Act (Canada). About Extendicare Extendicare i
Soins de santé et hôpitaux, Pharmaceutique, Santé
2026-06-15 8:00 AM EDT | Extendicare Inc.
Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study
Northvale, New Jersey--(Newsfile Corp. - June 15, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company engaged in the development, manufacture, and distribution of niche generic products, today reported positive results from a pivotal bioequivalence study for an undisclosed anticonvulsant generic drug product. IQVIA reported branded and generic product sales for the twelve months ending April 2026 of $840 million.
Soins de santé et hôpitaux, Pharmaceutique, Santé
2026-06-15 7:00 AM EDT | Elite Pharmaceuticals, Inc.
Cosmo Welcomes the Launches of Winlevi(R) in Austria and Germany
Ireland and Heppenheim, Germany--(Newsfile Corp. - June 15, 2026) - Cosmo N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) is pleased to announce the launch of its innovative acne cream Winlevi® (clascoterone 1% cream) in Austria and Germany by its commercial partner InfectoPharm Arzneimittel und Consilium GmbH (“InfectoPharm”). Winlevi® is available in both countries since June 1. Cosmo is the exclusive manufacturer of the product.
Soins de santé et hôpitaux, Santé
2026-06-15 1:01 AM EDT | Cosmo Pharmaceuticals N.V.
Bachem Holding AG Announces Capital Markets Day 2026
Bubendorf, Switzerland--(Newsfile Corp. - June 12, 2026) - Bachem Holding AG (SIX: BANB) will host its Capital Markets Day on 26 November 2026 at The Circle Convention Center, Hyatt Regency Zurich Airport, as well as virtually. This hybrid event will provide insights into the company's strategic priorities, business outlook, and key developments.
Biotechnologies, Produits chimiques, Soins de santé et hôpitaux, Pharmaceutique
2026-06-12 11:47 AM EDT | Bachem Holding AG
Healthcare Special Opportunities Fund Announces June 2026 Quarterly Distribution
Toronto, Ontario--(Newsfile Corp. - June 12, 2026) - LDIC Inc. (the "Manager"), the manager of Healthcare Special Opportunities Fund (TSX: MDS.UN) (the "Fund"), a closed-end investment fund, today announces the quarterly distribution of CDN$0.05923 per Class A unit and US$0.05261 per Class U unit. The distribution will be paid on or before July 10, 2026, to unitholders of record on June 30, 2026. For further information pleas
Services bancaires / financiers, Soins de santé et hôpitaux
2026-06-12 10:29 AM EDT | Healthcare Special Opportunities Fund
Senior Care Authority Releases Father's Day Guide with 10 Warning Signs that Aging Parents Need Support
Incline Village, Nevada--(Newsfile Corp. - June 12, 2026) - Senior Care Authority shares insights on Father’s Day visits, highlighting how the occasion can help families notice when aging parents may be struggling in ways not visible from a distance. "Holiday visits are often when families first notice something has changed," said Frank Samson, founder and CEO of Senior Care Authority. "It's not always dramatic. Sometimes it's a messy kitchen or a conversation that feels sli
Soins de santé et hôpitaux, Santé
2026-06-12 9:00 AM EDT | Senior Care Authority
WELL Health Provides a Corporate Update on Circle Medical
WELL Health is providing a corporate update on its majority-owned subsidiary Circle Medical, a leading telehealth platform delivering accessible, insurance-based primary care across the United States. Circle Medical continues to expand access to care, having more than tripled the number of commercially insured patients eligible to receive care on its platform over the last year, supported by strong double-digit growth in new patient bookings and activations in May 2026 as compare
Technologies, Logiciels, Soins de santé et hôpitaux, Santé
2026-06-12 7:00 AM EDT | WELL Health Technologies Corp.
Cosmo Welcomes the Launch of Winlevi(R) in Key European Markets by Its Partner Glenmark
Dublin, Ireland--(Newsfile Corp. - June 11, 2026) - Cosmo N.V. (SIX: COPN) (XETRA: C43) (“Cosmo”) is pleased to make known that its commercial partner Glenmark Specialty S.A (GSSA), a wholly-owned subsidiary of Glenmark Pharmaceuticals Ltd., today announced the launch of Winlevi® (clascoterone 10 mg/g cream) across key markets in Europe. This follows the grant of marketing authorization of the product for the tr
Soins de santé et hôpitaux, Santé
2026-06-11 1:19 AM EDT | Cosmo Pharmaceuticals N.V.
Adia Nutrition Inc. Delivers Exciting Update: Name Change to Adia Med Inc. Now Official in Nevada
Winter Park, Florida--(Newsfile Corp. - June 10, 2026) - Adia Nutrition Inc. (OTCQB: ADIA) is pleased to confirm that the State of Nevada has officially approved the company's name change to Adia Med Inc.
Soins de santé et hôpitaux, Santé
2026-06-10 9:15 AM EDT | Adia Nutrition Inc.
Aurora Spine Grants Stock Options
Carlsbad, California--(Newsfile Corp. - June 9, 2026) - Aurora Spine Corporation (TSXV: ASG) (OTCQB: ASAPF) ("Aurora Spine" or the "Company"), a leader in the development of groundbreaking medical devices for spinal surgery, today announced that it has granted stock options (the "Options") to acquire 2,020,000 common shares of the Company. A total of 1,300,000 were granted to members of the Company's Board of Directors and the balance to certain employees of the Compa
2026-06-09 6:07 PM EDT | Aurora Spine Corporation
Medexus Announces License and Supply Deal for UM171 Cell Therapy in Canada
Ontario and Chicago, Illinois--(Newsfile Corp. - June 9, 2026) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF)
Biotechnologies, Soins de santé et hôpitaux, Pharmaceutique, Santé
2026-06-09 5:30 PM EDT | Medexus Pharmaceuticals Inc.
BioMark Secures Broad U.S. Patent for Urine-Based Lung Cancer Screening, Expanding Differentiated Liquid Biopsy Testing Platform
Vancouver, British Columbia--(Newsfile Corp. - June 9, 2026) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCQB: BMKDF) ("BioMark" or the "Company"), a leading developer of liquid biopsy technologies for early cancer detection, is pleased to announce that the United States Patent and Trademark Office (USPTO) has issued a Notice of Patent Allowance for Application No. 18/304,741, titled "Method of Detecting Lung Cancer." The allowed patent covers the proprietary use of ur
Technologies, Biotechnologies, Soins de santé et hôpitaux
2026-06-09 8:30 AM EDT | BioMark Diagnostics, Inc.
Altus Copper Provides Corporate Updates
Vancouver, British Columbia--(Newsfile Corp. - June 8, 2026) - Altus Copper Corp. (the "Company") is pleased to provide a summary of several board and management changes undertaken over the past 18 months. On March 18, 2025, Zayn Kalyan resigned as Chief Executive Officer and a director of the Company. The Company does not currently have a CEO, although Arndt Roehlig was engaged as President on March 18, 2025. On August 8, 2025, Jason Baker was appointed as Chief Financial
Aliments / boissons, Soins de santé et hôpitaux, Santé
2026-06-08 9:15 PM EDT | Altus Copper Corp.
Adia Nutrition Launches Dynamic New Subsidiary ADIA Life LLC in Florida to Supercharge Distribution and Unlock a Full Spectrum of Life-Transforming Wellness Solutions
Winter Park, Florida--(Newsfile Corp. - June 8, 2026) - Adia Nutrition (OTCQB: ADIA), a leader in advanced nutrition and regenerative health products, today announced the official launch of its new wholly-owned subsidiary, ADIA Life LLC, headquartered in the state of Florida.
Soins de santé et hôpitaux, Santé
2026-06-08 12:51 PM EDT | Adia Nutrition Inc.
CardioComm Solutions and Predictiv AI Enter into Strategic AI Collaboration
Toronto, Ontario--(Newsfile Corp. - June 8, 2026) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a provider of consumer heart monitoring, remote patient monitoring and medical electrocardiogram ("ECG") software solutions, is pleased to announce that it has entered into a strategic collaboration, joint development and intellectual property agreement with Predictiv AI Inc. ("Predictiv AI") of North York, Ontario. The agreement establishes a framework under which
Technologies, Soins de santé et hôpitaux, Santé
2026-06-08 9:11 AM EDT | CardioComm Solutions, Inc.
TelyRx Surpasses 1 Million Prescriptions, Underscoring Growing Demand for Digital Pharmacy
Clearwater, Florida--(Newsfile Corp. - June 8, 2026) - TelyRx Holdings Inc. (TSX: TELY) (OTCQX: TELYF), a technology-enabled healthcare and online pharmacy platform focused on expanding access to FDA-approved medications across the United States, today announced it has surpassed one million prescriptions filled nationwide since inception, a major milestone in the company's growth. The milestone reflects growing consumer demand for healthcare experiences that are easier to navigate, more
Soins de santé et hôpitaux, Santé
2026-06-08 8:00 AM EDT | TelyRx
TelyRx Commences Trading on the OTCQX Market in the United States
Clearwater, Florida--(Newsfile Corp. - June 5, 2026) - TelyRx Holdings Inc. (TSX: TELY) (OTCQX: TELYF) ("TelyRx" or the "Company"), a vertically integrated, technology-enabled healthcare and pharmacy services company, announced today that its subordinate voting shares will commence trading on the OTCQX Best Market ("OTCQX"), the premier tier of the OTC Markets Group in the United States, under the symbol "TELYF". TelyRx's subordinate voting shares will also continue to trade on the TSX under
Soins de santé et hôpitaux, Santé
2026-06-05 7:00 AM EDT | TelyRx
WELL Health Strengthens Clinical and Public Sector Leadership with Appointment of Dr. Andrew Bond as Chief Health Officer and Head of Public Sector
WELL appoints accomplished physician executive and health system leader Dr. Andrew Bond as Chief Health Officer and Head of Public Sector to lead clinical governance and performance, government relations, and growth in public sector solutions. Dr. Bond brings more than 20 years of clinical and healthcare leadership experience spanning primary care, emergency medicine, public policy, and digital health, across organizations including GreenS
Technologies, Logiciels, Soins de santé et hôpitaux, Santé
2026-06-05 6:30 AM EDT | WELL Health Technologies Corp.
Senior Care Authority Kicks off Alzheimer's and Brain Awareness Month with Six Science-Backed Habits That May Help Reduce Dementia Risk
Incline Village, Nevada--(Newsfile Corp. - June 4, 2026) - An estimated 7.4 million Americans aged 65 and older are now living with Alzheimer's disease, according to the Alzheimer's Association's 2026 Alzheimer's Disease Facts and Figures report, and that number is projected to climb to nearly 13 million by 2050. Yet the same report found that while 99% of adults say brain health is as important as physical health, only 9% say the
Soins de santé et hôpitaux, Santé
2026-06-04 11:07 AM EDT | Senior Care Authority
Envoy Medical to Present at Planet MicroCap Conference Las Vegas on June 16th-18th
White Bear Lake, Minnesota--(Newsfile Corp. - June 4, 2026) - Envoy Medical® Inc. (NASDAQ: COCH), a hearing health company pioneering fully implanted hearing solutions, today announced that Brent Lucas, CEO of Envoy Medical, will present at the Planet MicroCap Conference on June 16-18, 2026, in Las Vegas, NV. Planet MicroCap Las Vegas 2026 Dates: June 16-18, 2026 Location: Bellagio Hotel & Ca
Biotechnologies, Soins de santé et hôpitaux
2026-06-04 8:30 AM EDT | Envoy Medical, Inc.